Functional Germline DNA Repair Mutations as Predictors of Acute Radiodermatitis in Breast Cancer
Diagnostics · 11.03.2026 · 16 (6) · 833
DOI: 10.3390/diagnostics16060833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 11.03.2026. Verfasst von Andreea Cătană und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Sciences, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Acute radiotherapy-induced skin toxicity is a common complication in breast cancer treatment, with marked interindividual variability not fully explained by clinical factors. This study investigated the contribution of germline mutations in DNA repair and tumor suppressor genes to acute radiodermatitis in a homogeneous cohort treated with hypofractionated intensity-modulated radiotherapy with inverse planning, with adjustment for potential lifestyle confounders.
Methods
Mutations were grouped into four functional categories: homologous recombination repair (HRR), Fanconi anemia (FA), DNA damage response (DDR), and tumor suppressor (TS) genes. Ordinal logistic regression models adjusted for clinical covariates evaluated pooled and functional category-specific mutation effects.
Results
Overall, any mutation significantly increased the risk of higher-grade acute radiodermatitis (OR = 2.24, p = 0.003), an effect driven primarily by HRR and FA mutations, as exclusion of these mutations rendered the association non-significant (OR = 1.785, p = 0.064). Functional category-based analyses showed that HRR (OR = 2.60, p = 0.002) and FA (OR = 2.62, p = 0.002) mutations were the strongest predictors, reflecting overlapping roles in double-strand break and interstrand crosslink repair. DDR and TS mutations showed no significant effect.
Conclusions
These results highlight the key role of high-fidelity DNA repair in normal tissue radiosensitivity and demonstrate that functional genetic stratification has diagnostic value as a pre-treatment predictive biomarker framework, enabling identification of patients at increased risk of acute skin toxicity and supporting personalized radiotherapy planning.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Sciences, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Department of Oncogenetics, "Prof. Dr. I. Chiricuță" Institute of Oncology, 400015 Cluj-Napoca, Romania.
- Regional Laboratory Cluj-Napoca, Department of Medical Genetics, Regina Maria Health Private Network, 400363 Cluj-Napoca, Romania.
- Department of Radiotherapy, "Prof. Dr. I. Chiricuță" Institute of Oncology, 400015 Cluj-Napoca, Romania.
- Genetic Centre Laboratory, Department of Medical Genetics, Regina Maria Health Private Network, 011376 Bucharest, Romania.
- 1st Department of Oncologic Surgery, "Prof. Dr. I. Chiricuță" Institute of Oncology, 400015 Cluj-Napoca, Romania.
ORCID-Profile: Patriciu Achimaș-Cadariu, Lorin-Manuel Pîrlog
Zitieren
APA
Cătană, A., Belbe, A. A., Martin, D. L., Ciliboaie, H., Militaru, M. S., Iordănescu, I. I., Achimaș-Cadariu, P., & Pîrlog, L. M. (2026). Functional Germline DNA Repair Mutations as Predictors of Acute Radiodermatitis in Breast Cancer. Diagnostics, 16(6), 833. https://doi.org/10.3390/diagnostics16060833
Vancouver
Cătană A, Belbe AA, Martin DL, Ciliboaie H, Militaru MS, Iordănescu II, et al. Functional Germline DNA Repair Mutations as Predictors of Acute Radiodermatitis in Breast Cancer. Diagnostics. 2026;16(6):833. doi:10.3390/diagnostics16060833
BibTeX
@article{Ctan2026,
author = {Cătană, Andreea and Belbe, Andrada-Adelaida and Martin, Daniela Laura and Ciliboaie, Horațiu and Militaru, Mariela Sanda and Iordănescu, Irina Ioana and Achimaș-Cadariu, Patriciu and Pîrlog, Lorin-Manuel},
title = {Functional Germline DNA Repair Mutations as Predictors of Acute Radiodermatitis in Breast Cancer},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {6},
pages = {833},
doi = {10.3390/diagnostics16060833}
}
EUVIMED